BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9719151)

  • 1. The nucleotide sequence of the IgA1 hinge region in IgA nephropathy.
    Greer MR; Barratt J; Harper SJ; Allen AC; Feehally J
    Nephrol Dial Transplant; 1998 Aug; 13(8):1980-3. PubMed ID: 9719151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J; Allen AC
    J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
    Kokubo T; Hashizume K; Iwase H; Arai K; Tanaka A; Toma K; Hotta K; Kobayashi Y
    Nephrol Dial Transplant; 2000 Jan; 15(1):28-33. PubMed ID: 10607764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
    Leung JC; Poon PY; Lai KN
    J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.
    Gharavi AG; Moldoveanu Z; Wyatt RJ; Barker CV; Woodford SY; Lifton RP; Mestecky J; Novak J; Julian BA
    J Am Soc Nephrol; 2008 May; 19(5):1008-14. PubMed ID: 18272841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
    J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
    Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
    J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
    Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
    J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
    J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
    Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I; Gejyo F
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis.
    Allen AC; Willis FR; Beattie TJ; Feehally J
    Nephrol Dial Transplant; 1998 Apr; 13(4):930-4. PubMed ID: 9568852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients.
    Allen AC; Bailey EM; Brenchley PE; Buck KS; Barratt J; Feehally J
    Kidney Int; 2001 Sep; 60(3):969-73. PubMed ID: 11532091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.
    Allen AC; Harper SJ; Feehally J
    Clin Exp Immunol; 1995 Jun; 100(3):470-4. PubMed ID: 7774058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H; Yamamoto K; Iwayama S; Iwase H; Takasaki A; Takahashi K; Fujita Y; Sugiyama S; Hiki Y
    J Nephrol; 2010; 23(1):70-6. PubMed ID: 20091489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.